X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atherosclerosis (22) 22
humans (21) 21
animals (18) 18
index medicus (18) 18
mice (14) 14
expression (11) 11
macrophages (11) 11
inflammation (9) 9
conjugated linoleic acid (8) 8
membrane proteins (8) 8
mice, inbred c57bl (8) 8
mice, knockout (8) 8
prostaglandins (8) 8
atherosclerosis - drug therapy (7) 7
cyclooxygenase 1 (7) 7
cyclooxygenase 2 (7) 7
linoleic acids, conjugated - pharmacology (7) 7
peripheral vascular disease (7) 7
pharmacology & pharmacy (7) 7
prostacyclin (7) 7
apolipoproteins e - genetics (6) 6
cardiac & cardiovascular systems (6) 6
cyclooxygenase (6) 6
female (6) 6
male (6) 6
ppar-gamma (6) 6
unsaturated fatty acids (6) 6
analysis (5) 5
apolipoproteins (5) 5
atherosclerosis - metabolism (5) 5
cyclooxygenase 2 inhibitors (5) 5
immunology (5) 5
inhibition (5) 5
isoenzymes - antagonists & inhibitors (5) 5
macrophages - drug effects (5) 5
prostaglandin-endoperoxide synthases - metabolism (5) 5
smooth-muscle-cells (5) 5
activation (4) 4
anti-inflammatory agents, non-steroidal - therapeutic use (4) 4
apolipoproteins e - deficiency (4) 4
apoptosis (4) 4
aspirin (4) 4
biochemistry & molecular biology (4) 4
blood platelets - metabolism (4) 4
cells, cultured (4) 4
conjugated linoleic-acid (4) 4
cyclooxygenase inhibitors - pharmacology (4) 4
gene-expression (4) 4
genetic aspects (4) 4
health aspects (4) 4
hematology (4) 4
in-vitro (4) 4
isoenzymes - metabolism (4) 4
knockout mice (4) 4
linoleic acids (4) 4
macrophages - metabolism (4) 4
macrophages - pathology (4) 4
monocytes - drug effects (4) 4
phenotype (4) 4
proliferation (4) 4
prostaglandin-endoperoxide synthases - physiology (4) 4
research (4) 4
abridged index medicus (3) 3
apoe (3) 3
apolipoprotein e (3) 3
arteriosclerosis (3) 3
atherosclerosis - prevention & control (3) 3
atherosclerotic plaques (3) 3
biology (3) 3
cardiovascular (3) 3
cell biology (3) 3
cell movement - drug effects (3) 3
cell proliferation (3) 3
cholesterol (3) 3
cox-2 inhibitors (3) 3
cyclooxygenase inhibitors - therapeutic use (3) 3
development and progression (3) 3
diabetes (3) 3
dinoprostone - biosynthesis (3) 3
disease (3) 3
endocrinology & metabolism (3) 3
gene expression (3) 3
gene expression profiling (3) 3
in-vivo (3) 3
isoenzymes - biosynthesis (3) 3
lipids (3) 3
plaque microenvironment (3) 3
plaques (3) 3
prostaglandin-endoperoxide synthases - biosynthesis (3) 3
receptor-deficient mice (3) 3
resolution (3) 3
thromboxane b2 - blood (3) 3
6-ketoprostaglandin f1 alpha - analogs & derivatives (2) 2
6-ketoprostaglandin f1 alpha - urine (2) 2
acyclic or carbocyclic compounds (2) 2
adhesion (2) 2
adult (2) 2
aged (2) 2
alpha (2) 2
anti-inflammatory (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 05/2019, Volume 10, p. 463
Atherosclerosis is a chronic progressive inflammatory disease where advanced lesions can eventually completely obstruct blood flow resulting in clinical... 
atherosclerosis | CIRCULATING MICRORNAS | monocytes | CONJUGATED LINOLEIC-ACID | BLOOD MONOCYTE SUBSETS | RECEPTOR | MICRORNA-155 PROMOTES ATHEROSCLEROSIS | macrophages | inflammation | FOAM CELL-FORMATION | miR-155 | PHARMACOLOGY & PHARMACY | INFLAMMATORY RESPONSE | NF-KAPPA-B | EXPRESSION
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 01/2017, Volume 83, Issue 1, pp. 46 - 53
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 01/2017, Volume 83, Issue 1, pp. 152 - 162
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 07/2016, Volume 7, p. 275
Journal Article
European Journal of Immunology, ISSN 0014-2980, 10/2011, Volume 41, Issue 10, pp. 2840 - 2851
Journal Article
Diabetes, ISSN 0012-1797, 12/2018, Volume 67, Issue 12, pp. 2657 - 2667
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 11/2017, Volume 16, Issue 1, pp. 143 - 13
Background: Macrophages play a pivotal role in atherosclerotic plaque development. Recent evidence has suggested the glucagon-like peptide-1 receptor (GLP-1R)... 
Monocytes | MΦ2 macrophages | Plaque microenvironment | Anti-inflammatory | Atherosclerosis | ACTIVATION | PLACEBO | CARDIAC & CARDIOVASCULAR SYSTEMS | M Phi 2 macrophages | RISK | PEPTIDE-1 ANALOG LIRAGLUTIDE | INDIVIDUALS | HYPERGLYCEMIA | INFLAMMATION | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | RECEPTOR AGONIST LIRAGLUTIDE | Hypoglycemic Agents - therapeutic use | Cell Line | Leukocytes, Mononuclear - metabolism | Atherosclerosis - drug therapy | Leukocytes, Mononuclear - drug effects | Apolipoproteins E - deficiency | Humans | Mice, Inbred C57BL | Atherosclerosis - metabolism | Hypoglycemic Agents - pharmacology | Mice, Knockout | Macrophages - metabolism | Phenotype | Animals | Liraglutide - pharmacology | Liraglutide - therapeutic use | Macrophages - drug effects | Mice | Oxidative stress | CC chemokine receptors | Flow cytometry | Populations | Peptides | High cholesterol diet | Glucagon | Cardiovascular disease | Inflammatory response | Bifurcations | Mannose | Metabolic syndrome | Macrophages | Western blotting | High fat diet | Interleukin 6 | Genotype & phenotype | Reduction | Cell fate | Apolipoprotein E | Rodents | Interleukin 1 | Bone marrow | Lesions | Glucagon-like peptide 1 | Enzyme-linked immunosorbent assay | Phenotypes | Cytokines | CCR7 protein | Medical treatment | Markers | Inflammation | Cholesterol | Calories | Studies | CD163 antigen | Weight control | Arteriosclerosis | Coronary vessels | Interleukin 10 | In vivo methods and tests | Diabetes | Human behavior | Surface markers
Journal Article
Journal Article